Santhera Pharmaceuticals’ License Agreement With Sperogenix Therapeutics

Federica Tiefenthaler Europe Legal Chronicle
Tagged:

chellenberg Wittmer advised Santhera Pharmaceuticals on the deal.Swiss Biotech Santhera has entered an exclusive licence agreement with China-based Sperogenix Therapeutics for the development of Vamorolone for…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here